HRT Financial’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$142K Buy
+32,885
New +$144K ﹤0.01% 3516
2026
Q1
Sell
-15,665
Closed -$58K 4463
2025
Q4
$58K Buy
+15,665
New +$134K ﹤0.01% 2858
2025
Q2
Sell
-14,818
Closed -$163K 3294
2025
Q1
$163K Buy
+14,818
New +$177K ﹤0.01% 2069
2024
Q3
Sell
-9,205
Closed -$531K 2923
2024
Q2
$531K Buy
+9,205
New +$451K ﹤0.01% 1276
2024
Q1
Sell
-10,160
Closed -$824K 2864
2023
Q4
$824K Buy
+10,160
New +$827K 0.01% 1086
2023
Q3
Sell
-1,556
Closed -$510K 2895
2023
Q2
$510K Buy
1,556
+729
+88% +$222K ﹤0.01% 1354
2023
Q1
$228K Sell
827
-1,356
-62% -$498K ﹤0.01% 1865
2022
Q4
$845K Buy
+2,183
New +$616K 0.01% 1064

Other funds holding OM

HRT Financial's OM Position: Q2 2026 in Review

HRT Financial opened a new position in Outset Medical (OM) in Q2 2026: 32,885 shares worth $142K. The stake represents ﹤0.01% of the portfolio and ranks #3516 among its holdings. This is a return to the name: HRT Financial previously reported a position in OM as recently as Q4 2025.

HRT Financial first reported a position in OM in Q4 2022 and has held it in 8 quarters since. The position peaked at $845K in Q4 2022. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • HRT Financial held 32,885 shares of Outset Medical worth $142K as of Q2 2026.
  • Outset Medical was a new HRT Financial position in Q2 2026.
  • Outset Medical made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3516 holding.
  • HRT Financial first reported a position in Outset Medical in Q4 2022 and has held it in 8 quarters since.
  • HRT Financial's Outset Medical position peaked at $845K in Q4 2022.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.